Clinical Trial Update: Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing once-daily tiotropium 5 µg to twice-daily tiotropium 2.5 µg as add-on therapy to inhaled corticosteroids in asthma, with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Spiriva (tiotropium)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2014-08-13